Open | - |
Close | - |
Volume / Avg. | 1.645K / 218.692K |
Day Range | - - - |
52 Wk Range | 1.050 - 3.970 |
Market Cap | $37.489M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 2.21% |
Days to Cover | 4.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of icad (NASDAQ: ICAD) through any online brokerage.
Other companies in icad’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX), Definitive Healthcare (NASDAQ:DH) and TruBridge (NASDAQ:TBRG).
The latest price target for icad (NASDAQ: ICAD) was reported by Lake Street on Wednesday, July 19, 2023. The analyst firm set a price target for 5.00 expecting ICAD to rise to within 12 months (a possible 251.49% upside). 5 analyst firms have reported ratings in the last year.
The stock price for icad (NASDAQ: ICAD) is $1.4225 last updated Today at March 19, 2024 at 9:14 AM EDT.
There are no upcoming dividends for icad.
icad’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for icad.
icad is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.